128 related articles for article (PubMed ID: 17961421)
1. [Serum autoantibodies against the cardiac beta(1)-adrenergic receptor in patients with chronic heart failure: clinical characteristics and response to carvedilol].
Chen J; Yang XC; Wang SY; Zhu JG; Liu XL; Wu YF; Zhang L
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):599-602. PubMed ID: 17961421
[TBL] [Abstract][Full Text] [Related]
2. [The effect of carvedilol on cardiac function and autoantibodies against the cardiac receptors].
Chen J; Hu DY; Zhang L; Liu XL; Wu YF; Li J
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jun; 33(6):498-501. PubMed ID: 16053779
[TBL] [Abstract][Full Text] [Related]
3. [Effects of carvedilol and metoprolol on expression of autoantibodies against cardiac adrenergic receptors in aged patients with chronic heart failure and ventricular arrhythmia].
Li XD; Wang JC; Ye L; Zhao Y; Zhou NN; Zhu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jul; 38(7):584-7. PubMed ID: 21055277
[TBL] [Abstract][Full Text] [Related]
4. A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure.
Nagatomo Y; Yoshikawa T; Kohno T; Yoshizawa A; Baba A; Anzai T; Meguro T; Satoh T; Ogawa S
J Card Fail; 2009 Apr; 15(3):224-32. PubMed ID: 19327624
[TBL] [Abstract][Full Text] [Related]
5. Presence of autoantibody directed against β1-adrenergic receptors is associated with amelioration of cardiac function in response to carvedilol: Japanese Chronic Heart Failure (J-CHF) Study.
Nagatomo Y; Yoshikawa T; Okamoto H; Kitabatake A; Hori M;
J Card Fail; 2015 Mar; 21(3):198-207. PubMed ID: 25528200
[TBL] [Abstract][Full Text] [Related]
6. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
[TBL] [Abstract][Full Text] [Related]
7. Autoantibody against beta1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment.
Miao GB; Liu JC; Liu MB; Wu JL; Zhang G; Chang J; Zhang L
Eur J Clin Invest; 2006 Sep; 36(9):614-20. PubMed ID: 16919043
[TBL] [Abstract][Full Text] [Related]
8. Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure.
Mortara A; La Rovere MT; Pinna GD; Maestri R; Capomolla S; Cobelli F
J Am Coll Cardiol; 2000 Nov; 36(5):1612-8. PubMed ID: 11079666
[TBL] [Abstract][Full Text] [Related]
9. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
[TBL] [Abstract][Full Text] [Related]
10. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
[TBL] [Abstract][Full Text] [Related]
11. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
12. [Association of T190C polymorphism of β3 adrenergic receptor gene with response to carvedilol in patients with chronic heart failure].
Yu H; Wei F; Qian G; Li L; Zhang C; Cheng Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Feb; 32(1):101-4. PubMed ID: 25636111
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against the myocardial beta1-adrenergic and M2-muscarinic receptors in patients with congestive heart failure.
Zhang L; Hu D; Li J; Wu Y; Liu X; Yang X
Chin Med J (Engl); 2002 Aug; 115(8):1127-31. PubMed ID: 12215275
[TBL] [Abstract][Full Text] [Related]
14. Relation between heart rate, heart rhythm, and reverse left ventricular remodelling in response to carvedilol in patients with chronic heart failure: a single centre, observational study.
Arnold RH; Kotlyar E; Hayward C; Keogh AM; Macdonald PS
Heart; 2003 Mar; 89(3):293-8. PubMed ID: 12591834
[TBL] [Abstract][Full Text] [Related]
15. Sudden cardiac death risk factors in patients with heart failure treated with carvedilol.
Nessler J; Nessler B; Kitliński M; Libionka A; Kubinyi A; Konduracka E; Piwowarska W
Kardiol Pol; 2007 Dec; 65(12):1417-22; discussion 1423-4. PubMed ID: 18181053
[TBL] [Abstract][Full Text] [Related]
16. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
17. [The effect of carvedilol on apoptosis gene PDCD5 expression in chronic heart failure patients].
Wu Y; Nie XY; Hu DY; Lu PN; Zhang GQ; Luo L
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):676-8. PubMed ID: 15932730
[TBL] [Abstract][Full Text] [Related]
18. Renal and cardiac function during alpha1-beta-blockade in congestive heart failure.
Heitmann M; Davidsen U; Stokholm KH; Rasmussen K; Burchardt H; Petersen EB
Scand J Clin Lab Invest; 2002; 62(2):97-104. PubMed ID: 12004934
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary study on the effect of carvedilol on children with primary endocardial fibroelastosis].
Li R; Yi QJ; Qian YR; Liu XY; Zhong JR; Bai YH; Mi Q; Li XL
Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):684-7. PubMed ID: 19099859
[TBL] [Abstract][Full Text] [Related]
20. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
Razzolini R; Tarantini G; Boffa GM; Orlando S; Iliceto S
Ital Heart J; 2004 Jul; 5(7):517-22. PubMed ID: 15487269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
